piperacillin--tazobactam-drug-combination and Hypokalemia

piperacillin--tazobactam-drug-combination has been researched along with Hypokalemia* in 4 studies

Reviews

1 review(s) available for piperacillin--tazobactam-drug-combination and Hypokalemia

ArticleYear
Severe acute hypokalaemia associated with piperacillin/tazobactam in an HIV-infected patient under antiretroviral therapy with tenofovir alafenamide: case report and literature review.
    Sexual health, 2020, Volume: 17, Issue:2

    Piperacillin/tazobactam is a commonly prescribed antimicrobial agent. Tenofovir alafenamide (TAF) is increasingly being used in antiretroviral therapy (ART) of HIV. Herein we report a case of a 57-year-old male with AIDS receiving TAF-containing ART in whom severe refractory hypokalaemia developed after coadministration of piperacillin/tazobactam for suspected hospital-acquired infection. Upon withdrawal of piperacillin/tazobactam, serum potassium concentrations returned to normal within 2 days. Hypokalaemia is a rare adverse effect of piperacillin/tazobactam and may be aggravated with the underlying use of TAF. We also reviewed past reported cases of hypokalaemia after piperacillin/tazobactam administration. We want to highlight that a more cautious approach should be considered when combining piperacillin/tazobactam and TAF in clinical practice.

    Topics: Acquired Immunodeficiency Syndrome; Alanine; Antiviral Agents; Humans; Hypokalemia; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Tenofovir

2020

Other Studies

3 other study(ies) available for piperacillin--tazobactam-drug-combination and Hypokalemia

ArticleYear
[Incidence and Risk Factors of Hypokalemia in Tazobactam/Piperacillin-administered Patients].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2019, Volume: 139, Issue:12

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Biomarkers; Body Mass Index; Cohort Studies; Female; Humans; Hypokalemia; Incidence; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Potassium; Retrospective Studies; Risk Factors; Severity of Illness Index

2019
Severe acute hypokalaemia secondary to voriconazole. Uncommon pharmacological causes of hypokalaemia.
    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2011, Volume: 31, Issue:1

    Topics: Acetamides; Amikacin; Anti-Bacterial Agents; Antifungal Agents; Candidiasis, Invasive; Drug Therapy, Combination; Humans; Hypokalemia; Linezolid; Lung Diseases, Fungal; Male; Middle Aged; Oxazolidinones; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Potassium Chloride; Pyrimidines; Triazoles; Voriconazole

2011
Electrolytes imbalance: a rare side effect of piperacillin/ tazobactam therapy.
    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2010, Volume: 20, Issue:6

    Electrolytes imbalance has been reported with the use of several antimicrobials. We report a case of severe hypokalemia secondary to piperacillin/tazobactam in a patient with normal renal function and normal serum potassium level who had presented with a fractured neck of femur. The electrolytes abnormality was corrected once piperacillin/tazobactam was stopped. To our knowledge, this is the first case to describe an early severe hypokalemia induced by piperacillin/ tazobactam therapy in an otherwise healthy individual.

    Topics: Aged; Anti-Bacterial Agents; Female; Femoral Neck Fractures; Humans; Hypokalemia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Respiratory Tract Infections

2010